Figure 2.
Relapse-free survival by treatment arm. Ofatumumab (OFA; intervention; blue line) and rituximab (RTX; control; red line) (OR, 1.06; 95% CI, 0.55 to 2.06).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.